News

Keep abreast of the latest breakthroughs

Allinky presents its inflammation program at AseBio Investor Day in San Sebastián
May 16, 2024

AseBio Investor Day is a key event that gathers prominent figures from the biotechnology and investment communities, fostering collaboration…

Allinky is awarded a Seal of Excellence from Horizon Europe’s EIC Accelerator Program
March 11, 2024

Allinky Biopharma is thrilled to announce that it has been awarded the prestigious Seal of Excellence from the European Innovation Council (EIC)…
Allinky will attend AseBio Investor Day 2024

Allinky will attend AseBio Investor Day 2024
January 9, 2024

Allinky will attend the next edition of AseBio Investor Day , which will be held in Donostia-San Sebastian on May 15th. AseBio Investor Day…

European patent granted to Allinky
December 20, 2023

On December 20th, 2023, the European Patent Office published the mention of the grant of the European Patent for the invention 'PYRIDIN-SULFONAMIDE…
Allinky executes a new capital increase of 2 million euros

Allinky executes a new capital increase of 2 million euros
December 2, 2023

Last December 2023, Allinky executed a new capital increase of €2 million to conclude the preclinical evaluation of its most advanced candidate,…